[Correction of functional and structural changes of the intestine by ursosan in patients with absence of the gall-bladder].
Kozlova
I V
IV
Volkov
S V
SV
D002756:Cholagogues and Choleretics / Q000008:administration & dosage / Q000627:therapeutic use*; D002763:Cholecystectomy; D002764:Cholecystitis / Q000601:surgery; D004415:Dyspepsia / Q000209:etiology / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D005243:Feces / Q000382:microbiology; D005500:Follow-Up Studies; D005704:Gallbladder / Q000601:surgery*; D006801:Humans; D007422:Intestines / Q000187:drug effects* / Q000382:microbiology / Q000473:pathology; D011183:Postoperative Complications / Q000209:etiology / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D011795:Surveys and Questionnaires; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use*
D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid